3,3'-diselenodipropionic acid and Cancer of Skin

3,3'-diselenodipropionic acid has been researched along with Cancer of Skin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, W; Chen, T; Li, X; Wong, YS; Zheng, S; Zheng, W	1

Other Studies

1 other study(ies) available for 3,3'-diselenodipropionic acid and Cancer of Skin

Article	Year
Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk. Oncotarget, 2014, Sep-15, Volume: 5, Issue:17 Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; In Situ Nick-End Labeling; Melanoma; Propionates; Reactive Oxygen Species; Receptor Cross-Talk; RNA Interference; Selenium Compounds; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand	2014

Article

Year

Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk.

Oncotarget, 2014, Sep-15, Volume: 5, Issue:17

Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; In Situ Nick-End Labeling; Melanoma; Propionates; Reactive Oxygen Species; Receptor Cross-Talk; RNA Interference; Selenium Compounds; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2014